Experts' views on COVID-19 vaccination and the impact of the pandemic on patients with Gaucher disease
Br J Haematol
.
2021 Oct;195(2):e135-e137.
doi: 10.1111/bjh.17693.
Epub 2021 Jul 5.
Authors
Uri Hamiel
1
2
,
Alina Kurolap
1
,
Ian J Cohen
2
3
,
Noa Ruhrman-Shahar
3
,
Tova Hershkovitz
4
5
,
Claus Niederau
6
,
Ari Zimran
7
8
,
Shoshana Revel-Vilk
7
8
,
Majdolen Istaiti
7
,
Maria Domenica Cappellini
9
10
,
Hagit Baris Feldman
1
2
Affiliations
1
Genetics Institute and Genomics Center, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
2
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
3
Recanati Genetics Institute, Rabin Medical Center, Petah Tikva, Israel.
4
The Genetics Institute, Rambam Health Care Campus, Haifa, Israel.
5
Rappaport Faculty of Medicine, Technion, Haifa, Israel.
6
Medical Pracitice Oberhausen, Oberhausen, Germany.
7
Gaucher Unit, Shaare Zedek Medical Centre, Jerusalem, Israel.
8
Faculty of Medicine, Hebrew University, Jerusalem, Israel.
9
Department of Medicine and Medical Specialities, Fondazione IRCSS Cà Granda, Milan, Italy.
10
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
PMID:
34227097
PMCID:
PMC8444856
DOI:
10.1111/bjh.17693
No abstract available
Publication types
Letter
MeSH terms
COVID-19 / epidemiology*
COVID-19 / prevention & control
COVID-19 Vaccines / administration & dosage*
Cross-Sectional Studies
Gaucher Disease / drug therapy*
Humans
Pandemics
Substances
COVID-19 Vaccines